]]]]]]]]]]]] BOWEL CANCER AND HEALTH RISKS [[[[[[[[[[[[
From Newsletter of (10/30/89)
Thomas A. Dorman, M.D.
(Freeman 93401DORM)
Cancers begin small, in one place, and grow. Later they
spread. That is what usually happens. One of the reasons skin cancers
are not such a bad thing is because we can see them when they start
and do something. Cancers on the inside of the body are not easy to
see. Nonetheless many of the cancers which affect the internal organs
begin on the lining of the food tube, which is called the gastero-
intestinal tract. It is not a very polite fact, but a medical one,
that cancers of the lower end are more common than the upper. The
bowel can be inspected, the cancers identified and removed before it
is too late. It is also known that cancers in the bowel can bleed, and
not surprisingly, large cancers which have grown from little cancers
and therefore have been there longer are more likely to bleed more
often and in larger amounts.
First a question for which you do not need to be a doctor: If
you wanted to see if the sky is cloudy would you look out of the
window, or would you put your hand out to feel for rain?
Now a question for which you need a very impressive medical
degree: If you wanted to see if there was a cancer in the bowel would
you look in there, or would you test for bleeding?
Dorman's Law No 2. When exhorted on scientific grounds to
do the right thing, and when authority and statistics are quoted, look
out for sleight of hand. Somebody is obscuring something. The profit
and loss account might be a factor.
Let us do a few rough calculations. The population over 45
years old in the U.S. is 73,461 million. The cause of death is 325,000
for heart disease, 191,700 for malignancies(1985 statistics). The
expected incidence for colon cancers is 150,000, most of which occur
in people over 60 years old. 40% of diagnosed bowel cancer cases are
usually cured, which is the reaper's way of saying that death is
postponed for another diagnosis. I am not being facetious when I put
it this way, because Dorman's first law of medicine is that humans are
mortal. Excuse me, but I just have to digress.
I have been in S.L.O. for a dozen years, and about a year after my
arrival I was looking after a gentleman aged 102. Though he had been
in hospital and had been given a number of medical labels, like heart
disease, he was hale and hearty. There was nothing wrong with him. He
was cheerful and bright and at times grumpy and tired. He died. There
was no special illness, no complaint from his heart or anything else.
Yours truly wrote on the death certificate that he died of old age. A
cardinal mistake. My education began. The coroner asked politely. I
was strong. He died of old age. But soon "Sacramento" called. They
only asked: Dr. what is your licence number? Does the BMQA know about
you yet? Which university did you come from? In America, Dr., everyone
has a diagnosis! It didn't take long for the patient to have died of
heart disease (on the certificate). Lesson: Officially we are
immortal.
The law of certificates.
They have to look impressive and stick to the rules. Facts and
common sense don't count. But let's go back to bowel cancers.
It is estimated that occult blood test screening in the stool
(like putting your hand out to see if it is raining) costs $2.50 per
screen per year and will pick up about 2.25 cancers per thousand of
population screened, in a hitherto unscreened population. As most
bowel cancers develop in individuals over 60, for the purpose of this
little chat I will assume a retired population. The average money
expended per person per year in America (for everything and that
includes what you spend and what the governments spends on each human
being) can perhaps be approximated by dividing the gross national
product by the population P 3,947 billion for 239,283,000 = $14,565
per person (1985 numbers). It is hard to predict the increase in life
span from a cure of bowel cancer as a general average, but a
reasonable assumption is 7 years. 40% cure of 150,000 cases represents
60,000 cases a year to whom 7 years might be added. This is a best
case scenario. Now assume non-productive life years; i.e., retired
`years'. Next we should multiply the cost of these years, snatched
from the reaper by their estimated total. 60,000 x $14,565 = $6,117
billion. This is the `cost' per annum. It is the national expenditure
on non-productive American's life/years. Keep this little number in
mind for a few more lines. The plot thickens. Now the average expense
for a terminal cancer illness has been estimated at $21,200 for the
last year of life, but we can't deduct this figure from the expense
because everyone dies sometime. (The law of mortality). As an average,
over the long haul, the death rate won't change, though the cause
might. Everyone born to woman has to die! We will only find the same
diagnoses in older people. That is a backwards way of saying people
live longer.
So let's go back to looking at the cost of prevention again,
in my analogy looking for rain versus feeling for it. Sigmoidoscopy
finds cancers earlier. First of all we should remember that it rains
when it rains and bowel cancers bleed when they bleed. Most bowel
cancers are without symptoms until it is too late. We should also
remember that the unimproved cure rate from colon cancer reflects just
those reported as colon cancer, not those reported as colon polyps,
with malignancy in situ. In any case reporting of cancerous polyps is
incomplete.
Assume sigmoidoscopy to 60cm @ $150, every three years in the
population at risk over 45. That is 3,82 million sigmoidoscopies =
$573 million per year. At best this expense will detect about 110,000
cancers. (About 2 per thousand will develop cancer a year in the
population over 45.) The screening cost P per cancer detected P is
about $75,000. Given the 7 year addition to the life expectancy the
life-expense, for those who got the extra years, will be $185,000. The
national RloadS, not the good life - we are talking money and
government controlled expense is $27 billion per annum. (Not all bowel
cancers will be detected with sigmoidoscopy alone, assume an 80%
detection rate.) An estimate for the decreased incidence of cancer
after the first year of mass screening is in order in these
calculations, because each cancer develops over about 4-5 years from a
small polyp to a bad one. Against this we need to weigh the expense in
screening the extra lives around. People who have had cancer are at
increased risk for further cancer and screening every one to two years
is recommended. Let us assume these numbers are about equal. We are
left then with the following: For an 80% or better chance of
prevention, i.e. early detection, you can spend $150 every four years
for sigmoidoscopy. This will give you a 1/8 chance of increasing your
life expectancy about 7 years and allowing you to spend an extra
$75,000 for living expenses. If you rely on screening the cancers with
bleeding when bleeding eventually occurs, i.e. later in the cancer's
growth, you have a 40% chance of a cure. You are not likely to save
money on your terminal illness as long as you are mortal. $27 billion
per year spent on extra life and health costs represents 0.68% of the
gross domestic product. Most cancers develop in the distal, or far
down part, of the large bowel. A few develop higher up. To see them a
longer instrument, a colonoscope, is needed. The test is more
unpleasant and a tiny bit more risky. Barium enemas are also useful
for detecting bowel cancer. In convenience and costs, the curve
becomes exponential. In this practice your doctor has adopted the
policy of recommending sigmoidoscopy every four years. Testing for
occult blood in the stool is likely to pick up later and larger and
more dangerous cancers - a second best. It is cheaper to the national
exchequer. It would be cheapest, of course, if we all died on the day
of retirement. In our civilization a doctor's responsibility is to his
patients, their longevity and well-being. When the day comes that the
doctor's responsibility is to the national exchequer - look out for
the statistics.
Here are the References:-
The World in Figures; The Economist, 1986.
Block, G.E. Colon cancer: diagnosis and prognosis in the
elderly. Geriatrics; 1989 May.
Enblad, P.; Adami, H.O.; Bergstrom, R.; Glimelius, B.;
Krusemo, U.; Pahlman, L. Improved survival of patients with cancers of
the colon and rectum? J Natl Cancer Inst; 1988 Jun 15.
Eliakim, R.; Shabetai, O.; Rachmilewitz, D. Screening for
fecal occult blood in Israel. Different approaches to recruitment. J
Clin Gastroenterol; 1988 Apr.
Long, S.H.; Gibbs, J.O.; Crozier, J.P.; Cooper, D.I. Jr;
Newman, J.F. Jr; Larsen, A.M. Medical expenditures of terminal cancer
patients during the last year of life. Inquiry.; 1984 Winter.
Ayiomamitis, A. The epidemiology of malignant neoplasms of the
large intestine in Canada: 1941-1985. J Clin Gastroenterol; 1989 Feb.
Olsen, H.W.; Lawrence, W.A.; Snook, C.W.; Mutch, W.M. Risk
factors and screening techniques in 500 patients with benign and
malignant colon polyps. An urban community experience. Dis Colon
Rectum; 1988 Mar.
* * *
Return to the ground floor of this tower
Return to the Main Courtyard
Return to Fort Freedom's home page